Mayo Clinic Talks

This episode was recorded June 17, 2020. 

To claim credit visit: https://ce.mayo.edu/covid19podcast

Guest:   J. Taylor Hays, M.D. (@jtaylorhays), Robert Vassallo, M.D.

Host: Amit K. Ghosh, M.D., M.B.A. (@AmitGhosh006) 

Is the act of smoking a risk factor for transmission? Does nicotine protect against severe COVID-19? Dr. Hays and Dr. Vassallo discuss what is currently known about the risks of smoking in regard to COVID-19 and treatment of patients who smoke, during the pandemic.

AskMayoExpert COVID-19 Resources: https://askmayoexpert.mayoclinic.org/navigator/COVID-19

Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. 

This episode was recorded June 17, 2020. 

To claim credit visit: https://ce.mayo.edu/covid19podcast

Guest:  J. Taylor Hays, M.D. (@jtaylorhays), Robert Vassallo, M.D.

Host: Amit K. Ghosh, M.D., M.B.A. (@AmitGhosh006) 

Is smoking a risk factor for severe disease in COVID-19? How accurate is the documentation of smoking in COVID-19 cohorts currently published? What role should a smoking history play in the prognosis and management of COVID-19? Drs. Hays and Vassallo discuss the prevalence of smoking worldwide, the impact of documentation, and the role smoking may play in COVID-19.

AskMayoExpert COVID-19 Resources: https://askmayoexpert.mayoclinic.org/navigator/COVID-19

Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. 

Guest: J. Taylor Hays, M.D. (@jtaylorhays)

Host: Darryl S. Chutka, M.D. (@ChutkaMD)

How do you treat nicotine dependent patients with other substance use disorders, and which do you start with? Does quitting tobacco increase these patients’ risk for relapse of other substances? What should you do with the patient that has “tried everything?” Dr. Taylor Hays sheds light on helping some of your most challenging patients to quit smoking.

Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.

Guest: J. Taylor Hays, M.D. (@jtaylorhays)

Host: Darryl S. Chutka, M.D. (@ChutkaMD)

Through a combination of health policy, smoke-free environmental changes, education, and treatment availability, smoking prevalence among adults has dropped significantly. But that’s not the case for our patients with mental health disorders. Dr. Taylor Hays dispels the myths around nicotine dependence and mental health disorders like depression, anxiety, bipolar disorder, and schizophrenia. He’ll fill you in on how to help these patients quit and what quitting looks like for this patient population.

Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.

Guest: J. Taylor Hays, M.D. (@jtaylorhays)

Host: Darryl S. Chutka, M.D. (@ChutkaMD)

Quitting smoking is one of the hardest things for our patients to do. The clinical target of nicotine replacement and other quit therapies is not to smoke. Clinical outcomes vary among the pharmacologic treatments, relapses are common, and some patients become addicted to those treatments. Dr. J. Taylor Hays unravels some of the do’s and don’ts when it comes to counseling and treating these patients.

Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.

Guest: J. Taylor Hays, M.D. (@jtaylorhays)

Host: Darryl S. Chutka, M.D. (@ChutkaMD)

What’s the difference between e-cigarettes, vaping, and the newly FDA authorized “heat-not-burn” or IQOS devices? Do they really help our patients stop smoking and what data is available on the safety of these products? Listen now to hear Dr. Taylor Hays discuss these points and more.

Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.

Deeper Dive:

• The FDA Authorization of IQOS: https://bit.ly/2XV2cLw 
• A Randomized Trial of E-Cigarettes versus Nicotine-Replacement Therapy: https://www.nejm.org/doi/full/10.1056/NEJMoa1808779